CompletedNCT05870605
Intuniv prescribing patterns across European countries
About this title
Read the official source — NCT05870605Observational studyAges 6+GermanyADHD
Understand this study
Who was this study for?
Listed age limits: from 6 years.
- Listed locations
- MunichSee all locations and recruitment
Study information
Study start dateStarted: November 15, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 5,000
- Sponsor
- Shire
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Other
- Locations
- Germany
- Age range
- Over 6 Years
- Official registry ID
- NCT05870605
- Official title
Show the full official title
Drug Utilisation Study of Intuniv® (Guanfacine Extended Release) in European Countries
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Munich
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Shire.
Who was this study for?
Listed age limits: from 6 years.
